RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Novel steroids having the formula ##STR1## wherein R.sup.1 is
selected from the group consisting of methyl, ethyl, and propyl;
R.sup.2 is selected from the group consisting of H and methyl;
R.sup.3 is selected from the group consisting of OXO and
H(OR.sup.5); ##STR2## wherein R.sub.4 is selected from the group
consisting of H.sub.2, H(methyl), H(Cl), H(F), and .dbd.CH.sub.2 ;
or ##STR3## wherein R is selected from the group consisting of H,
methyl, Cl, and F. Q-S is selected from the group consisting of
--CH.dbd.CH-- and --CH.sub.2 CH--. Also disclosed is a method for
making and therapeutically using the steroids and for making the
intermediates.